𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial

✍ Scribed by Marc S Sabatine; Elliott M Antman; Petr Widimsky; Iftikhar O Ebrahim; Robert G Kiss; André Saaiman; Rostislav Polasek; Charles F Contant; Carolyn H McCabe; Eugene Braunwald


Book ID
117305367
Publisher
The Lancet
Year
2009
Tongue
English
Weight
247 KB
Volume
374
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES